Specifically, miR-199a-5p has been reported to target DDR1 in hepatocellular carcinoma [20], acute myeloid leukemia [28], colorectal cancer [29] and cutaneous squamous cell carcinoma [30]. The gene discussed is DDR1; the disease is hepatocellular carcinoma.